Product Description
an inhibitor of the human immunodeficiency virus (Sourced from: https://pubmed.ncbi.nlm.nih.gov/22393121/)
Mechanisms of Action: NNRT Inhibitor
Novel Mechanism: No
Modality: Unknown
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Company: Boehringer Ingelheim
Company Location: Europe
Company Founding Year: 1885
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: HIV Infections
Phase 1: Healthy Volunteers
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT02253940 |
NCT02253940 | P1 |
Completed |
Healthy Volunteers |
2006-12-01 |
2019-03-20 |
||
NCT02253927 |
NCT02253927 | P1 |
Completed |
Healthy Volunteers |
2006-08-01 |
2019-03-20 |
Treatments |
|
NCT02259868 |
NCT02259868 | P1 |
Completed |
Healthy Volunteers |
2005-09-01 |
2019-03-20 |
Treatments |
|
NCT02256826 |
NCT02256826 | P1 |
Completed |
Healthy Volunteers |
2005-06-01 |
2019-03-20 |
Treatments |
|
NCT02253901 |
NCT02253901 | P1 |
Completed |
Healthy Volunteers |
2005-05-01 |
2019-03-20 |
Treatments |
|
NCT02256774 |
NCT02256774 | P1 |
Completed |
Healthy Volunteers |
2005-05-01 |
2019-03-20 |
Treatments |
|
NCT02257021 |
NCT02257021 | P1 |
Completed |
Healthy Volunteers |
2005-05-01 |
2019-03-20 |
Treatments |
|
NCT02253914 |
NCT02253914 | P1 |
Completed |
Healthy Volunteers |
2004-12-01 |
2019-03-20 |
||
NCT02253953 |
NCT02253953 | P1 |
Completed |
Healthy Volunteers |
2003-12-01 |
2019-03-20 |
Treatments |
|
NCT02257008 |
NCT02257008 | P1 |
Completed |
Healthy Volunteers |
2003-12-01 |
2019-03-20 |
Treatments |
|
NCT02254538 |
1 - 200 mg) | P1 |
Completed |
Healthy Volunteers |
2003-02-01 |
2019-03-20 |
Treatments |
|
2005-004698-39 |
2005-004698-39 | P2 |
Completed |
HIV Infections |
2007-09-12 |
2022-03-12 |
Treatments |
|
NCT00294372 |
NCT00294372 | P2 |
Terminated |
HIV Infections |
2007-09-01 |
2019-03-21 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|